SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-24-000140
Filing Date
2024-03-06
Accepted
2024-03-06 16:50:40
Documents
81
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K seel-20231231x10k.htm   iXBRL 10-K 2286535
2 EX-4.6 seel-20231231xex4d6.htm EX-4.6 45171
3 EX-23.1 seel-20231231xex23d1.htm EX-23.1 11297
4 EX-31.1 seel-20231231xex31d1.htm EX-31.1 16125
5 EX-31.2 seel-20231231xex31d2.htm EX-31.2 16282
6 EX-32.1 seel-20231231xex32d1.htm EX-32.1 9089
7 EX-32.2 seel-20231231xex32d2.htm EX-32.2 9250
8 EX-97 seel-20231231xex97.htm EX-97 53049
9 GRAPHIC seel-20231231xex23d1001.jpg GRAPHIC 5351
  Complete submission text file 0001410578-24-000140.txt   9812979

Data Files

Seq Description Document Type Size
10 EX-101.SCH seel-20231231.xsd EX-101.SCH 89973
11 EX-101.CAL seel-20231231_cal.xml EX-101.CAL 44774
12 EX-101.DEF seel-20231231_def.xml EX-101.DEF 301929
13 EX-101.LAB seel-20231231_lab.xml EX-101.LAB 684717
14 EX-101.PRE seel-20231231_pre.xml EX-101.PRE 493348
83 EXTRACTED XBRL INSTANCE DOCUMENT seel-20231231x10k_htm.xml XML 1402557
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22245 | Film No.: 24726662
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)